Get Multiple Sclerosis while younger if have a poor CYP24A1 vitamin D gene – May 2023

The CYP24A1 gene variant rs2762943 is associated with low serum 1,25-dihydroxyvitamin D levels in multiple sclerosis patients

Eur J Neurol . 2023 May 14. doi: 10.1111/ene.15866
Sunny Malhotra # 1, Luciana Midaglia # 1, Omar Chuquisana 2, Nikolaos A Patsopoulos 3 4 5, Roser Ferrer 6, Marina Giralt 6, Nicolas Fissolo 1, Elia Gil-Varea 1, Juan Carlos Triviño 7, Jan D Lünemann 2, Xavier Montalban 1, Manuel Comabella 1

1,25(OH)2 D levels much lower in those with poor CPY24A1

This decrease would not be noticed by a standard Vitamin D test


Background: Vitamin D is considered to play a role in multiple sclerosis (MS) etiopathogenesis. We recently identified a polymorphism in the CYP24A1 gene, rs2762943, that was associated with an increased MS risk. CYP24A1 encodes a protein involved in the catabolism of the active form of vitamin D. We investigated the immunological effects of carrying the rs2762943 risk allele, and its role as genetic modifier.

Methods: Serum levels of 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D (1,25(OH)2 D) were measured in a cohort of 167 MS patients. In a subgroup of patients, expression levels of MHC class II and co-stimulatory molecules were determined by flow cytometry, and serum levels of proinflammatory (IFNG, GM-CSF, CXCL13) and anti-inflammatory (IL-10) cytokines and neurofilament light chain were measured by single-molecule array assays. The effect of the rs2762943 polymorphism on disease activity and disability measures was evaluated in 340 MS patients.

Results: Compared to non-carriers, carriers of the rs2762943 risk allele were characterized by reduced levels of 1,25(OH)2 D (p=0.0001), and elevated levels of IFNG (p=0.03) and GM-CSF (p=0.008), whereas no significant differences were observed for the other markers. The presence of the rs2762943 risk allele had no significant impact on disease activity and disability outcomes during follow-up. However, risk allele carriers were younger at disease onset (p=0.04).

Conclusions: These findings suggest that the CYP24A1 rs2762943 polymorphism plays a more important role on MS susceptibility than on disease prognosis, and is associated with lower 1,25(OH)2 D levels and heightened pro-inflammatory environment in MS patients.
 Download the PDF from VitaminDWiki

VitaminDWiki – CYP24A1 contains

Proper activationmakes sure that Vitamin D does not accumulate in the body
Too much activationLess vitamin D actually gets to cells
Too little activation Vitamin D accumulates to toxic levels ( <1 in 10,000 people)

Blood test does not show when a poor CYP24A1 gene stops Vitamin D from getting to cells
in Visio for 2023 Click here for more information
Several Cancers and health problems appear to protect themselves by changing CYP24A1 activation

VitaminDWiki – Overview MS and vitamin D contains

Clinical interventions have shown that Vitamin D can prevent, treat, and even cure Multiple Sclerosis, at a tiny fraction of the cost of the drugs now used to treat it, and without side effects.

Summary: lack of consensus on how much to prevent, treat, or cure MS.

VitaminDWiki - 21 studies in both categories MS and Genetics (general)

This list is automatically updated

VitaminDWiki - 11 studies in both categories MS and VDR Gene

This list is automatically updated

Multiple Sclerosis has been increasing at younger ages

MS Increase
click here for details

320 visitors, last modified 07 Jul, 2023,
Printer Friendly Follow this page for updates